Furthermore, the results of previous studies indicated that AC-93253 is a novel inhibitor of the class III histone deacetylase SIRT2 and can selectively induce cytotoxicity in cancer cells [36] and affect the expression of a variety of genes important for the acquisition of chemoresistance and the progression of disease in melanoma cells [37]. This evidence concerns the gene SIRT2 and cancer.